This topic contains a solution. Click here to go to the answer

Author Question: Which research design does NOT control for the effect of confounding variables? a. A-B b. A-B-A-B ... (Read 27 times)

armygirl

  • Hero Member
  • *****
  • Posts: 556
Which research design does NOT control for the effect of confounding variables?
 
  a. A-B
 b. A-B-A-B
 c. changing-criterion
  d. multiple-baseline

Question 2

DRO intervals should be gradually shortened over time.
 
  a. True
  b. False
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Bsand8

  • Sr. Member
  • ****
  • Posts: 327
Answer to Question 1

a

Answer to Question 2

False




armygirl

  • Member
  • Posts: 556
Reply 2 on: Jun 21, 2018
Excellent


Animal_Goddess

  • Member
  • Posts: 339
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

A recent study has found that following a diet rich in berries may slow down the aging process of the brain. This diet apparently helps to keep dopamine levels much higher than are seen in normal individuals who do not eat berries as a regular part of their diet as they enter their later years.

Did you know?

IgA antibodies protect body surfaces exposed to outside foreign substances. IgG antibodies are found in all body fluids. IgM antibodies are the first type of antibody made in response to an infection. IgE antibody levels are often high in people with allergies. IgD antibodies are found in tissues lining the abdomen and chest.

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library